Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease

被引：80

作者：

Tan, Xin ^{[1
]}

Chen, Huaisheng ^{[2
]}

Zhang, Min ^{[3
,4
]}

Zhao, Ying ^{[5
]}

Jiang, Yichun ^{[2
]}

Liu, Xueyan ^{[2
]}

Huang, Wei ^{[3
,4
]}

Ma, Yingfei ^{[1
]}

机构：

[1] Chinese Acad Sci, Shenzhen Key Lab Synthet Genom, Guangdong Prov Key Lab Synthet Genom,Shenzhen Ins, CAS Key Lab Quantitat Engn Biol,Shenzhen Inst Syn, Shenzhen, Peoples R China

[2] South Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ, Dept Crit Care Med,Shenzhen Peoples Hosp,Second C, Shenzhen, Peoples R China

[3] Shenzhen Peoples Hosp, Shenzhen Inst Resp Dis, Shenzhen, Peoples R China

[4] Southern Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ,Shenzhen Peoples Hosp,Second Clin Med, Bacteriol & Antibacterial Resistance Surveillance, Shenzhen, Peoples R China

[5] Southern Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ, Dept Geriatr,Shenzhen Peoples Hosp,Second Clin Co, Shenzhen, Peoples R China

来源：

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷

关键词：

carbapenem-resistant Acinetobacter baumannii; lung infection; personalized phage therapy; phage; endotoxin;

D O I：

10.3389/fcimb.2021.631585

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Overuse of antibiotics in clinical medicine has contributed to the global spread of multidrug-resistant bacterial pathogens, including Acinetobacter baumannii. We present a case of an 88-year-old Chinese man who developed hospital-acquired pneumonia caused by carbapenem-resistant A. baumannii (CRAB). A personalized lytic pathogen-specific single-phage preparation was nebulized to the patient continuously for 16 days in combination with tigecycline and polymyxin E. The treatment was well tolerated and resulted in clearance of the pathogen and clinical improvement of the patient's lung function.

引用

页数：7

共 50 条

[31] Carbapenem-Resistant Acinetobacter baumannii Infection in Children From a Third-Level Hospital in Mexico: Clinical Characteristics and Molecular Epidemiology
Bejarano, Jose Ivan Castillo
Llaca Diaz, Jorge
Cavazos, Manuel Enrique
Alanis, Hugo Sanchez
de los Santos, Abiel Homero Mascarenas
Espinosa-Villasenor, Fernando
Samaniego, Rebeca Aguayo
Rodriguez, Daniel Siller
Vega, Nestor Casillas
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (07) : 431 - 435
[32] Intra-pleural colistin methanesulfonate therapy for pleural infection caused by carbapenem-resistant Acinetobacter baumannii: a successful case report
Rana, Muhammad Asim
El Rahman, Basheer Abd
Mady, Ahmed Fouad
Al Odat, Mohammed
AlHarthy, Abdurehman
Ramadan, Omar El Sayed
Mumtaz, Shahzad Ahmed
Omrani, Ali S.
INFECTIOUS DISEASE REPORTS, 2014, 6 (03) : 38 - 40
[33] In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
Nepka, Martha
Perivolioti, Efstathia
Kraniotaki, Eleni
Politi, Lida
Tsakris, Athanasios
Pournaras, Spyros
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6903 - 6906
[34] In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy
Segatore, Bernardetta
Piccirilli, Alessandra
Cherubini, Sabrina
Principe, Luigi
Alloggia, Giovanni
Mezzatesta, Maria Lina
Salmeri, Mario
Di Bella, Stefano
Migliavacca, Roberta
Piazza, Aurora
Meroni, Elisa
Fazii, Paolo
Visaggio, Daniela
Visca, Paolo
Cortazzo, Venere
De Angelis, Giulia
Pompilio, Arianna
Perilli, Mariagrazia
ANTIBIOTICS-BASEL, 2022, 11 (08):
[35] Isolation and characterization of Acinetobacter phage vAbaIN10 active against carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from healthcare-associated infections in Dakar, Senegal
Ndiaye, Issa
Debarbieux, Laurent
Sow, Ousmane
Ba, Bissoume Sambe
Diagne, Moussa Moise
Cisse, Abdoulaye
Fall, Cheikh
Dieye, Yakhya
Dia, Ndongo
de Magny, Guillaume Constantin
Seck, Abdoulaye
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2025, 41 : 151 - 158
[36] The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii ST2 isolates
Li, Jiaying
Fu, Yanjun
Zhang, Jisheng
Zhao, Yongxin
Fan, Xuecai
Yu, Lan
Wang, Yong
Zhang, Xiaoli
Li, Chunjiang
JOURNAL OF CHEMOTHERAPY, 2020, 32 (07) : 359 - 367
[37] Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy
Hiraki, Yoichi
Yoshida, Mayumi
Masuda, Yoko
Inoue, Daisuke
Tsuji, Yasuhiro
Kamimura, Hidetoshi
Karube, Yoshiharu
Takaki, Kazutaka
Kawano, Fumio
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (12) : E1234 - E1236
[38] Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused byKlebsiella pneumoniae,Pseudomonas aeruginosa,Acinetobacter baumannii: A Multicenter Study in China
Zhen, Xuemei
Lundborg, Cecilia Stalsby
Sun, Xueshan
Gu, Shuyan
Dong, Hengjin
ANTIBIOTICS-BASEL, 2020, 9 (08): : 1 - 13
[39] Increasing carbapenem-resistant Acinetobacter baumannii colonization and infection of patients in medical intensive care unit - experience of infection control intervention of one hospital in northern Taiwan
Chuang, Su-Yun
Peng, Miao-Chi
Su, Wen-Lin
Chen, Yi-Hsuan
Wu, Ping-Sheng
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S122 - S123
[40] Efficacy of tigecycline monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii sequence type 2 in Heilongjiang Province
Li, Jiaying
Fu, Yanjun
Zhang, Jisheng
Wang, Ying
Zhao, Yongxin
Fan, Xuecai
Yu, Lan
Wang, Yong
Zhang, Xiaoli
Li, Chunjiang
ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 651 - 659

← 1 2 3 4 5 →